Trials / Completed
CompletedNCT05397535
Baduanjin Lower Elevated Blood PreSsure Study
Traditional Exercise as Convenient Approach to Improve Health 1-Baduanjin Lower Elevated Blood PreSsure Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the effects of Baduanjin on blood pressure in individuals with high normal blood pressure (SBP 130-139 mmHg, and/or DBP 85-89 mmHg), as well as on glucose and lipid metabolism, quality of life, psychology, exercise, immune inflammation, endothelial function, and arterial stiffness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Baduanjin | Participants in Baduanjin group will receive health education on hypertension and attend a 4-hour class to learn Baduanjin before receiving the interventions after the randomization. Baduanjin exercise protocol is based on the "Fitness Qigong Baduanjin Standard" enacted by the General Administration of Sports in 2003. Each Badaunjin exercise session will last at least 30 minutes and be conducted at least 5 days per week for 52 weeks. These participants will be required to practice Baduanjin regularly, and the researchers will monitor their adherence to practice and provide reminders if needed. |
| BEHAVIORAL | Brisk walking | Participants in this group will receive health education on hypertension and practice brisk walking on their own for at least 30 minutes, at least 5 days per week for 52 weeks. These participants will be required to do brisk walking regularly, and the researcher will monitor their adherence to practice and provide reminders if needed. |
Timeline
- Start date
- 2022-06-05
- Primary completion
- 2024-07-04
- Completion
- 2025-07-11
- First posted
- 2022-05-31
- Last updated
- 2025-09-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05397535. Inclusion in this directory is not an endorsement.